Dr. Mark Clements, MD, PhD
Claim this profileChildren's Mercy Hospital
Studies Type 1 Diabetes
Studies Diabetes Mellitus
7 reported clinical trials
14 drugs studied
Area of expertise
1Type 1 Diabetes
IAA positive
IA-2 positive
ZnT8 positive
2Diabetes Mellitus
Affiliated Hospitals
Clinical Trials Mark Clements, MD, PhD is currently running
R2D2 Program
for Type 1 Diabetes
This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age children with T1D (called Remedy to Diabetes Distress \[R2D2\]) and to test the initial efficacy of R2D2 to reduce diabetes distress to improve children's glycemic control.
Recruiting1 award N/A
DFMO
for Type 1 Diabetes
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insulin? * Does it preserve what is left of the body's insulin production? Participants will take either DFMO or a placebo (looks like DFMO but has no active ingredients) two times a day for about 6 months. Participants will have 6 in person visits and 1 phone visit over a period of 12 months. Visits will include blood draws urine collection and other tests.
Recruiting0 awards Phase 26 criteria
More about Mark Clements, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mark Clements, MD, PhD has experience with
- Placebo
- Coin2Dose
- R2D2 MHealth Intervention
- DFMO
- ATTN
- REDCHiP
Breakdown of trials Mark Clements, MD, PhD has run
Type 1 Diabetes
Diabetes Mellitus
Hairy Cell Leukemia
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Clements, MD, PhD specialize in?
Mark Clements, MD, PhD focuses on Type 1 Diabetes and Diabetes Mellitus. In particular, much of their work with Type 1 Diabetes has involved IAA positive patients, or patients who are IA-2 positive.
Is Mark Clements, MD, PhD currently recruiting for clinical trials?
Yes, Mark Clements, MD, PhD is currently recruiting for 2 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Mark Clements, MD, PhD has studied deeply?
Yes, Mark Clements, MD, PhD has studied treatments such as Placebo, Coin2Dose, R2D2 mHealth intervention.
What is the best way to schedule an appointment with Mark Clements, MD, PhD?
Apply for one of the trials that Mark Clements, MD, PhD is conducting.
What is the office address of Mark Clements, MD, PhD?
The office of Mark Clements, MD, PhD is located at: Children's Mercy Hospital, Kansas City, Kansas 64108 United States. This is the address for their practice at the Children's Mercy Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.